Related references
Note: Only part of the references are listed.Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling
Xiaohong Zhang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)
Pyroptosis: A new frontier in cancer
Yuan Fang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong et al.
DRUG RESISTANCE UPDATES (2020)
Old wine in new bottles: Drug repurposing in oncology
Michal Antoszczak et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling
Sang Jun Han et al.
FASEB JOURNAL (2020)
Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer
Zhaodi Zheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models
Lucia Nappi et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K. G. K. Deepak et al.
PHARMACOLOGICAL RESEARCH (2020)
Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
Jian Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Current Advances in the Treatment of BRAF-Mutant Melanoma
Hima Patel et al.
CANCERS (2020)
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
Anna Diana et al.
CANCERS (2020)
Emerging Role of Circulating Tumor Cells in Gastric Cancer
Phung Thanh Huong et al.
CANCERS (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tao Gong et al.
NATURE REVIEWS IMMUNOLOGY (2020)
P21 activated kinase signaling in cancer
Chetan K. Rane et al.
SEMINARS IN CANCER BIOLOGY (2019)
Suppressing ROS-TFE3-dependent autophagy enhances ivermectin-induced apoptosis in human melanoma cells
Faming Deng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial
Brian D. Foy et al.
LANCET (2019)
Ivermectin: From theory to clinical application
Dalia S. Ashour
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs
Anna Markowska et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Autophagy-Independent Functions of the Autophagy Machinery
Lorenzo Galluzzi et al.
CELL (2019)
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-B pathway
Lu Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Genetic and molecular epidemiology of adult diffuse glioma
Annette M. Molinaro et al.
NATURE REVIEWS NEUROLOGY (2019)
Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro
Kitti Intuyod et al.
ANTICANCER RESEARCH (2019)
Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling
Hongxiu Diao et al.
BMC VETERINARY RESEARCH (2019)
The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1-NF-κB signaling axis
Yong Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway
Zhihong Dong et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance
Roger K. Prichard et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
Seul-Ki Choi et al.
CANCERS (2019)
Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
Wen-Hao Xu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Relationship between Oxidative Stress and Physical Activity in Women with Squamous Intraepithelial Lesions in a Cervical Cancer Control Program in the Brazilian Amazon
Saul Rassy Carneiro et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
The PAK1-Stat3 Signaling Pathway Activates IL-6 Gene Transcription and Human Breast Cancer Stem Cell Formation
Ji-Hyang Kim et al.
CANCERS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway
Ping Zhang et al.
CELL PROLIFERATION (2019)
Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
Jingjing Liu et al.
BIOSCIENCE REPORTS (2019)
A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma
Margreet G. Franken et al.
EUROPEAN JOURNAL OF CANCER (2019)
Epigenetic therapy for ovarian cancer: promise and progress
Sara Moufarrij et al.
CLINICAL EPIGENETICS (2019)
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
Yusuke Kobayashi et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
YAP and TAZ: a signalling hub of the tumour microenvironment
Francesca Zanconato et al.
NATURE REVIEWS CANCER (2019)
Apoptosis and Clearance of Apoptotic Cells
Shigekazu Nagata
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
Jiaqiao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies
Sun Min Lim et al.
CANCER TREATMENT REVIEWS (2018)
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial
Menno R. Smit et al.
LANCET INFECTIOUS DISEASES (2018)
Radiomics and radiogenomics in lung cancer: A review for the clinician
Rajat Thawani et al.
LUNG CANCER (2018)
Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth
Franck Gallardo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations
Andy Crump
JOURNAL OF ANTIBIOTICS (2017)
Ivermectin efficacy against Biomphalaria, intermediate host snail vectors of Schistosomiasis
Naftale Katz et al.
JOURNAL OF ANTIBIOTICS (2017)
Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment
Go J. Yoshida
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The global burden of women's cancers: a grand challenge in global health
Ophira Ginsburg et al.
LANCET (2017)
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer
Michiko Kodama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Ivermectin - Old Drug, New Tricks?
Roz Laing et al.
TRENDS IN PARASITOLOGY (2017)
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
Jinglu Wang et al.
ONCOTARGET (2017)
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
Sho Nambara et al.
ONCOTARGET (2017)
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis
Gloria Ravegnini et al.
AUTOPHAGY (2017)
Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
Min Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice
Miki Nishio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
Yingying Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Qianhui Dou et al.
CANCER RESEARCH (2016)
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
Roberto Wuerth et al.
DRUG DISCOVERY TODAY (2016)
Nano-based strategies to overcome p-glycoprotein-mediated drug resistance
Mehri Niazi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis
Jinlong Yin et al.
BRAIN (2015)
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi et al.
EMBO JOURNAL (2015)
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Yeon-Jin Kwon et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Recognition of the role of Natural Products as drugs to treat neglected tropical diseases by the 2015 Nobel prize in physiology or medicine
James H. McKerrow
NATURAL PRODUCT REPORTS (2015)
Differentiation and transdifferentiation potentials of cancer stem cells
Zhengjie Huang et al.
ONCOTARGET (2015)
Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death
Dobrin Draganov et al.
SCIENTIFIC REPORTS (2015)
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
Golam Kibria et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
The Four Faces of Autophagy: Implications for Cancer Therapy
David A. Gewirtz
CANCER RESEARCH (2014)
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
Alice Melotti et al.
EMBO MOLECULAR MEDICINE (2014)
Tracing PAKs from GI inflammation to cancer
Kyle Dammann et al.
GUT (2014)
Self-consumption: the interplay of autophagy and apoptosis
Guillermo Marino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders
Kelle M. Franklin et al.
FRONTIERS IN NEUROSCIENCE (2014)
Therapeutic Potential of Myrrh and Ivermectin against Experimental Trichinella spiralis Infection in Mice
Maha M. A. Basyoni et al.
KOREAN JOURNAL OF PARASITOLOGY (2013)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
Eloise Mastrangelo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Anti-inflammatory effects of ivermectin in mouse model of allergic asthma
Shuhan Yan et al.
INFLAMMATION RESEARCH (2011)
Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas
H-J Kwak et al.
ONCOGENE (2011)
Effects of Ivermectin on Blood-Feeding Phlebotomus papatasi, and the Promastigote Stage of Leishmania major
Hanafi A. Hanafi et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2011)
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
Sumaiya Sharmeen et al.
BLOOD (2010)
Cancer Stem Cells and Self-renewal
Catherine Adell O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin
Aili Gao et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice
J. Geyer et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Expansion and evolution of cell death programmes
Alexei Degterev et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Interaction of macrocyclic lactones with P-glycoprotein: Structure-affinity relationship
Anne Lespine et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)
A Lespine et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects
CA Guzzo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin
NS Kane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
